| Model Number |
413179 |
| Medical Device Problem Code |
Malposition of Device (2616)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Mdr 9618003-2023-00326 / device 1 of 5.Based on the available information, this event is deemed to be a reportable malfunction.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 1049092.Manufacturing site: 9618003.
|
| |
|
Event or Problem Description
|
|
The end user reported that the five wafers from a market unit found pre-cut hole significantly off centered prior to use and felt that the wafers were unusable.She stated the usual wear time of seven days.No photo is available at this time.
|
| |
|
Additional Manufacturer Narrative
|
|
(b)(4).Investigation summary: this issue is related to off center issues.The scope of this investigation covers all product family manufactured in convex 2pc line.This complaint has been evaluated for mdr reportability using mdr procedure work instruction.The 30-day mdr reportability decision for this complaint is yes.There was no harm reported with this complaint.The complaint as described has been reviewed and does not represent a threat to public safety and therefore does not warrant a 5-day report to the fda per 21 cfr part 803.This event is considered systemic based on the increase of complaints reported from(b)(6)2022, additional eleven (11) harm alert were reported by three different complainants and different period, in addition it was identified a nonconformance report before this investigation process.Based on that, actions will be taken to mitigate the failure mode reported.Refer to the process instruction (pi) and manufacturing lines impacted in this nonconformance below: convex 2-piece (pc) (process instruction (pi) convex 2-piece (pc) wafer sub-assembly machine 2 collaring operations).After 6 methodologies (ms) analysis was identified.Corrective and preventive actions will be taken for each of the causes identify for problem solution.Refer to corrective action / preventive actions (capa) plan record in database.The investigation has been approved and is complete.No additional action is required, and this complaint will be closed.This issue will be monitored through the post market product monitoring review process.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 1049092 manufacturing site: 9618003.
|
| |
|
Event or Problem Description
|
|
To date no additional patient or event details have been received.
|
| |
|
Search Alerts/Recalls
|